Victoria Seewaldt, M.D.

Professor of Medicine and Professor of Pathology
Duke University School of Medicine

Dr. Victoria Seewaldt is an internationally recognized expert in biomarker development, translational research, and breast cancer initiation who leads a bench-to-community research program focusing on identifying molecular targets for early detection and biomarker development. She earned her medical degree from the University of California-Davis School of Medicine.

Dr. Seewaldt has extensive basic- and translational research expertise in 3-D models of early mammary carcinogenesis, apoptotic signaling, and biomarker development. Her clinical and translational research involves multi-disciplinary, multi-institutional collaborations with basic, translational, and clinical scientists, with the goal of integrating novel functional imaging strategies with risk-markers to evaluate both environmental and epigenetic markers of risk. The proposed study will draw heavily on Dr. Seewaldt’s ability to span from lab to the community, as she has established a cohort of over 550 women who are at high risk for breast cancer, particularly triple-negative breast cancer. Uniquely, biomarkers identified in Dr. Seewaldt’s laboratory can be immediately tested among this cohort of high-risk patients as predictors of short-term breast cancer risk.